188 related articles for article (PubMed ID: 26984241)
1. Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Mahé I; Puget H; Buzzi JC; Lamuraglia M; Chidiac J; Strukov A; Helfer H; Perozziello A
Support Care Cancer; 2016 Aug; 24(8):3369-77. PubMed ID: 26984241
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study.
Cajfinger F; Debourdeau P; Lamblin A; Benatar V; Falvo N; Benhamou Y; Sevestre MA; Farge-Bancel D;
Thromb Res; 2016 Aug; 144():85-92. PubMed ID: 27318244
[TBL] [Abstract][Full Text] [Related]
3. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
[TBL] [Abstract][Full Text] [Related]
4. Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.
van der Wall SJ; Klok FA; den Exter PL; Barrios D; Morillo R; Cannegieter SC; Jimenez D; Huisman MV
J Thromb Haemost; 2017 Jan; 15(1):74-79. PubMed ID: 28012224
[TBL] [Abstract][Full Text] [Related]
5. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
Klamroth R; Sinn M; Pollich C; Bischoff S; Lohneis A; Orlovic AM; Wisłocka L; Habbel P; de Wit M; Späth-Schwalbe E; Scholz CW; Riess H
Oncol Res Treat; 2022; 45(4):178-185. PubMed ID: 34963120
[TBL] [Abstract][Full Text] [Related]
7. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
9. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
[TBL] [Abstract][Full Text] [Related]
11. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
[TBL] [Abstract][Full Text] [Related]
12. Treating patients with cancer and acute venous thromboembolism.
Donadini MP; Squizzato A; Ageno W
Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
[TBL] [Abstract][Full Text] [Related]
13. [Cancer and venous thromboembolism recurrence: The keys for an optimal management].
Mahé I; Benhamou Y; Helfer H; Chidiac J
Bull Cancer; 2018 May; 105(5):508-516. PubMed ID: 29544692
[TBL] [Abstract][Full Text] [Related]
14. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
15. [Cancer-associated venous thromboembolic recurrence: disregard of treatment recommendations].
Mahé I; Chidiac J
Bull Cancer; 2014 Mar; 101(3):295-301. PubMed ID: 24691192
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant medication adherence for cancer-associated thrombosis: A comparison of LMWH to DOACs.
Schaefer JK; Li M; Wu Z; Basu T; Dorsch MP; Barnes GD; Carrier M; Griggs JJ; Sood SL
J Thromb Haemost; 2021 Jan; 19(1):212-220. PubMed ID: 33104289
[TBL] [Abstract][Full Text] [Related]
17. VTE in patients with cancer--diagnosis, prevention, and treatment.
Lee A
Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
[TBL] [Abstract][Full Text] [Related]
18. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study.
Napolitano M; Saccullo G; Malato A; Sprini D; Ageno W; Imberti D; Mascheroni D; Bucherini E; Gallucci P; D'Alessio A; Prantera T; Spadaro P; Rotondo S; Di Micco P; Oriana V; Urbano O; Recchia F; Ghirarduzzi A; Lo Coco L; Mancuso S; Casuccio A; Rini GB; Siragusa S
J Clin Oncol; 2014 Nov; 32(32):3607-12. PubMed ID: 25267738
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]